Biomoda

Biomoda operates as an in vitro diagnostic company, developing tests and assays for the detection of cancer. The company's non-invasive diagnostics are based on a patented porphyrin application that preferentially binds to cancerous or abnormal cells extracted from sputum samples of the lungs. It is also involved in developing collection protocols and diagnostics for other cancers, including breast, oral, prostate, bladder, colorectal, and cervical cancer.